Regulatory & Compounding Status (April 2026)
Thymalin is not an FDA-approved human or veterinary drug product in the United States and is not an eligible bulk drug substance for 503A/503B compounding. While registered in the Russian Federation and CIS pharmacopeias as a thymic polypeptide preparation, it is documented here strictly for in vitro and preclinical laboratory research.
Molecular Properties
| Parameter | Value |
|---|---|
| Chemical Name | Thymalin / Thymic Extract Peptide Complex |
| Composition | Polypeptide fraction from bovine/porcine thymus gland; mixture of low MW peptides (1-10 kDa) |
| Primary Active Fraction | Thymic peptides primarily 2-20 amino acids in length |
| Molecular Weight Range | 1,000-10,000 Da (complex mixture) |
| CAS Number | 69558-55-0 (thymus extract) |
| Origin | Extracted from thymus gland tissue (bovine or porcine) |
| Bioregulator Class | Thymic peptide bioregulator; immunomodulatory complex |
Physical Properties
| Property | Specification |
|---|---|
| Appearance | White to light beige lyophilized powder |
| Solubility | Freely soluble in water, PBS, or saline at 1-10 mg/mL |
| pH (1% solution) | 5.5 - 7.5 |
| Hygroscopicity | Moderate; store desiccated |
| Solution Stability | Stable at 4°C for 7-10 days after reconstitution |
Analytical Specifications
| Test | Specification |
|---|---|
| Protein/Peptide Content | ≥85% (by Bradford or Lowry assay) |
| HPLC Profile | Characteristic peptide fingerprint; consistent with reference standard |
| Mass Spectrometry | MW distribution 1-10 kDa; multiple peptide species detected |
| Endotoxin Level | <10 EU/mg (tissue-derived product) |
| Heavy Metals | <20 ppm total; <2 ppm lead |
| Microbial Limits | Total aerobic count <1000 CFU/g; yeast/mold <100 CFU/g |
| Water Content | ≤10% (Karl Fischer) |
Storage Parameters
| Condition | Specification |
|---|---|
| Lyophilized Storage | -20°C, desiccated with desiccant |
| Lyophilized Shelf Life | 24 months when stored properly |
| Reconstituted Storage | 2-8°C for up to 10 days; -20°C for up to 3 months |
| Reconstitution Protocol | Add 1-2 mL sterile water or bacteriostatic water to 10 mg vial; gentle swirl 1-2 minutes |
| Freeze-Thaw Cycles | Maximum 3 cycles; activity may decrease with repeated freezing |
| Light Sensitivity | Low; standard laboratory storage acceptable |
Research Dosing Reference
| Application | Typical Dose Range | Frequency | Route |
|---|---|---|---|
| In Vitro Immune Cell Studies | 10-100 μg/mL | 24-72 hour incubation | Culture media |
| Small Animal Models (Rodent) | 0.5-5 mg/kg | Daily or every other day for 10-20 days | SC or IM injection |
| Immunomodulation Studies | 1-10 mg/kg | 5-10 consecutive days, then 10-day break | SC preferred |
| Age-Related Research | 2-5 mg/kg | Cyclic: 10 days on, 10 days off | SC or IM |
Note: Dosing information is for research reference only. Thymalin is intended strictly for laboratory research. Cyclic administration protocols commonly used to mimic physiological thymic function.
Key Research Studies
| Year | Study Focus | Key Findings |
|---|---|---|
| 1977 | Initial characterization of thymic peptides | Khavinson and Morozov isolated polypeptide fraction from calf thymus; demonstrated immunomodulatory activity in vitro with T-cell proliferation increased 40-60% at 10-50 μg/mL |
| 1988 | T-cell differentiation and maturation | Thymalin administration (1-5 mg/kg for 10 days) increased CD4+ and CD8+ T-cell counts by 25-45% in immunodeficient animal models; normalized thymulin and IL-2 levels |
| 2003 | Age-related immune function decline | Cyclic thymalin treatment (3 mg/kg, 10-day cycles) in aged rodents restored thymic cortical/medullary ratio; increased naive T-cell output by 35%; reduced inflammatory markers (TNF-α, IL-6) by 20-30% |
| 2015 | Mechanism and gene expression profiling | Microarray analysis revealed thymalin upregulated 87 immune-related genes; primary effects on T-cell receptor signaling, IL-2/IL-7 pathways, and thymopoiesis transcription factors (FOXN1, HOXA3) |
Mechanism of Action
| Biological Pathway | Description |
|---|---|
| Thymic Bioregulation | Polypeptide complex acts on thymic epithelial cells and developing thymocytes; mimics endogenous thymic hormones (thymopoietin, thymulin, thymosin) |
| T-Cell Differentiation | Promotes maturation of T-cell precursors in thymus; enhances positive/negative selection; increases CD4+/CD8+ differentiation |
| Immune Homeostasis | Normalizes T-helper (Th1/Th2) balance; modulates cytokine production (IL-2, IFN-γ, IL-4); enhances regulatory T-cell function |
| Gene Regulation | Influences expression of thymic transcription factors; upregulates genes involved in T-cell receptor rearrangement and thymopoiesis |
| Duration of Effect | Cumulative effects over 10-20 days; immunological changes persist 2-4 weeks post-treatment |
Quality Control Parameters
| Test Method | Acceptance Criteria |
|---|---|
| Appearance (visual) | White to light beige powder; uniform texture |
| Reconstitution Test | Complete dissolution within 2-3 minutes; clear to slightly opalescent |
| HPLC Fingerprint | Matches reference standard; correlation coefficient ≥0.95 |
| Protein Content (Bradford) | ≥85% peptide/protein content |
| Biological Activity | ≥80% potency vs reference in T-cell proliferation assay |
Bioregulator Peptide Class Comparison
Active Peptide Components (Representative)
| Component Type | MW Range | Proposed Function |
|---|---|---|
| Low MW Peptides (2-5 aa) | 200-600 Da | Rapid signaling; cytokine modulation |
| Medium MW Peptides (6-15 aa) | 600-2000 Da | T-cell receptor signaling; differentiation factors |
| Higher MW Peptides (16-50 aa) | 2000-6000 Da | Thymic hormone-like activity; gene regulation |
| Thymic Protein Fragments | 6000-10000 Da | Structural support; carrier functions |
External References
- Khavinson VKh, Morozov VG. Peptides of pineal gland and thymus prolong human life. Neuro Endocrinol Lett. 2003;24(3-4):233-40. https://pubmed.ncbi.nlm.nih.gov/14523364/
- Anisimov VN, et al. Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology. 2003;4(4):193-202. https://link.springer.com/article/10.1023/A:1025114230714
- National Center for Biotechnology Information. Thymic Peptides and Immune Function. https://www.ncbi.nlm.nih.gov/books/NBK532286/
Disclaimer: This product is intended for research use only. Not for human or veterinary diagnostic or therapeutic use. Thymalin is a tissue-derived complex; batch-to-batch variation may occur.
